Data from two Phase 2 studies in PBC show combination of OCA + bezafibrate achieved biochemical remission (normalization of ALP, total bilirubin, GGT, ALT and AST) in 40-44% of patients in the first 12 weeks OCA 5
LyondellBasell (LYB) has been selected to receive a €40 million grant from the European Union (EU) Innovation Fund. The grant will support the fully-electrified, industrial-scale advanced recycling demonstration plant